Li F - Search Results

1

Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience.

Yan F, Lu N, Gu Z, Huang W, Wang S, Gao X, Dou L, Li F, Wang L, Li M, Liu D, Gao C. Yan F, et al. Among authors: li f, li m. Ann Hematol. 2022 Feb;101(2):397-408. doi: 10.1007/s00277-021-04706-6. Epub 2021 Nov 4. Ann Hematol. 2022. PMID: 34735613

2

Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation.

Wang H, Zhao Y, Fang S, Wang L, Peng B, Yang J, Wang N, Du J, Li F, Jin X, Luan S, Wu X, Dou L, Liu D. Wang H, et al. Among authors: li f. Transplant Cell Ther. 2022 Jun;28(6):332.e1-332.e10. doi: 10.1016/j.jtct.2022.03.018. Epub 2022 Mar 18. Transplant Cell Ther. 2022. PMID: 35314377 Free article.

3

Increased risk of nonrelapse mortality post T-cell-replete haploidentical stem cell transplantation in patients with recurrence of acute graft-versus-host disease.

Peng B, Dou L, Yang J, Wang L, Li F, Gao X, Wang S, Jin X, Wang L, Jia M, Wang S, Li Y, Liu D. Peng B, et al. Among authors: li f, li y. Hematol Oncol. 2022 Oct;40(4):743-751. doi: 10.1002/hon.2999. Epub 2022 Apr 17. Hematol Oncol. 2022. PMID: 35385135

4

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

Dou LP, Li HH, Wang L, Li F, Huang WR, Yu L, Liu DH. Dou LP, et al. Among authors: li hh, li f. Chin Med J (Engl). 2018 Apr 5;131(7):790-798. doi: 10.4103/0366-6999.228243. Chin Med J (Engl). 2018. PMID: 29578122 Free PMC article.

5

[Clinical Characteristics, Treatment and Prognosis of PTLD after allogeneic Hematopoietic Stem Cell Transplantation].

Liu ZX, Huang WR, Li M, Gu ZY, Zhu CY, Lu N, Yao S, Wang SH, Li F, Gao XN, Liu DH, Gao CJ. Liu ZX, et al. Among authors: li f, li m. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Apr;26(2):535-540. doi: 10.7534/j.issn.1009-2137.2018.02.038. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018. PMID: 29665928 Chinese.

6

Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies.

Gao XN, Lin J, Wang SH, Huang WR, Li F, Li HH, Chen J, Wang LJ, Gao CJ, Yu L, Liu DH. Gao XN, et al. Among authors: li f, li hh. Ann Hematol. 2019 Jan;98(1):185-193. doi: 10.1007/s00277-018-3482-7. Epub 2018 Aug 24. Ann Hematol. 2019. PMID: 30143831 Free PMC article. Clinical Trial.

7

Outcomes of myeloablative peripheral blood stem cell transplantation for non-complete remission patients with relapsed/refractory peripheral T cell lymphomas.

Gu Z, Wang L, Wang Q, Li H, Bo J, Wang S, Zhao Y, Li F, Gao C, Liu D, Huang W. Gu Z, et al. Among authors: li f, li h. Ann Hematol. 2019 May;98(5):1237-1247. doi: 10.1007/s00277-018-3559-3. Epub 2018 Dec 11. Ann Hematol. 2019. PMID: 30539277 Clinical Trial.

8

Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia.

Gao XN, Lin J, Wang LJ, Li F, Li HH, Wang SH, Huang WR, Gao CJ, Yu L, Liu DH. Gao XN, et al. Among authors: li f, li hh. Ann Hematol. 2019 May;98(5):1267-1277. doi: 10.1007/s00277-019-03636-8. Epub 2019 Feb 12. Ann Hematol. 2019. PMID: 30747249 Clinical Trial.

9

Haploidentical, Unmanipulated Granulocyte Colony-Stimulating Factor (G-CSF)-Primed Peripheral Blood Stem Cell Transplants for Acute Myeloid Leukemia (AML) in Remission: A Single Center Experience.

Luo L, Fang S, Zhao S, Li F, Zhou Y, Guan L, Yang N, Gu Z, Lin T, Wang F, Zhu C, Huang W, Liu D, Gao C. Luo L, et al. Among authors: li f. Ann Transplant. 2019 Jun 21;24:367-373. doi: 10.12659/AOT.915182. Ann Transplant. 2019. PMID: 31221952 Free PMC article.

10

Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.

Gao XN, Lin J, Wang LJ, Li F, Li HH, Wang SH, Huang WR, Gao CJ, Yu L, Liu DH. Gao XN, et al. Among authors: li f, li hh. Ann Hematol. 2019 Sep;98(9):2163-2177. doi: 10.1007/s00277-019-03742-7. Epub 2019 Jun 26. Ann Hematol. 2019. PMID: 31243569 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,364 results

Search Page

Filters